Skip to main content

Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial.

PMID: 19688338
Journal: DIABETOLOGIA
Year: 2009
Reference: Diabetologia. 2009 Oct;52(10):2046-55.
Impact factor: 6.418
Publication type: Paper in international publication
Authors: Russell-Jones, D, Vaag, A, Schmitz, O, Sethi, B K, Lalic, N, Antic, S, Zdravkovic, M, Ravn, G M, Simo, R et al.
DOI: 10.1007/s00125-009-1472-y

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial.

PMID: 19688338
Journal: DIABETOLOGIA
Year: 2009
Reference: Diabetologia. 2009 Oct;52(10):2046-55.
Impact factor:
Publication type: Paper in international publication
Authors: Antic, S; Lalic, N; Ravn, G M; Russell-Jones, D; Schmitz, O; Sethi, B K; Simo, R; Vaag, A; Zdravkovic, M et al.
DOI: 10.1007/s00125-009-1472-y

Livedo racemosa as a marker of increased risk of recurrent thrombosis in patients with negative anti-phospholipid antibodies.

PMID: 19403146
Journal: MEDICINA CLINICA
Year: 2009
Reference: Med Clin (Barc). 2009 May 30;132(20):767-71.
Impact factor: 1.258
Publication type: Paper in national publication
Authors: Martinez-Valle, Ferran, Balada, Eva, Solans-Laque, Roser, Vilardell-Tarres, Miquel, Selva-O'Callaghan, Albert, Ordi-Ros, Josep et al.
DOI: 10.1016/j.medcli.2008.09.044

Livedo racemosa as a marker of increased risk of recurrent thrombosis in patients with negative anti-phospholipid antibodies.

PMID: 19403146
Journal: MEDICINA CLINICA
Year: 2009
Reference: Med Clin (Barc). 2009 May 30;132(20):767-71.
Impact factor:
Publication type: Paper in national publication
Authors: Balada, Eva; Martinez-Valle, Ferran; Ordi-Ros, Josep; Selva-O'Callaghan, Albert; Solans-Laque, Roser; Vilardell-Tarres, Miquel et al.
DOI: 10.1016/j.medcli.2008.09.044

Longitudinal pubertal growth according to age at pubertal growth spurt onset: data from a Spanish study including 458 children (223 boys and 235 girls).

PMID: 19845122
Journal: JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
Year: 2009
Reference: J Pediatr Endocrinol Metab. 2009 Aug;22(8):715-26.
Impact factor: 0.938
Publication type: Paper in international publication
Authors: Ferrandez, Angel, Carrascosa, Antonio, Audi, Laura, Baguer, Luis, Rueda, Carmen, Bosch-Castane, Juan, Gussinye, Miquel, Yeste, Diego, Labarta, Jose Ignacio, Mayayo, Esteban et al.
DOI:

Longitudinal pubertal growth according to age at pubertal growth spurt onset: data from a Spanish study including 458 children (223 boys and 235 girls).

PMID: 19845122
Journal: JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
Year: 2009
Reference: J Pediatr Endocrinol Metab. 2009 Aug;22(8):715-26.
Impact factor:
Publication type: Paper in international publication
Authors: Albisu, Maria A; Audi, Laura; Baguer, Luis; Bosch-Castane, Juan; Carrascosa, Antonio; Clemente, Maria; Fernandez-Cancio, Monica; Ferrandez, Angel; Gussinye, Miquel; Labarta, Jose Ignacio et al.
DOI:

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial.

PMID: 19748319
Journal: LANCET NEUROLOGY
Year: 2009
Reference: Lancet Neurol. 2009 Nov;8(11):987-97.
Impact factor: 14.27
Publication type: Paper in international publication
Authors: Kappos, Ludwig, Freedman, Mark S, Polman, Chris H, Edan, Gilles, Hartung, Hans-Peter, Miller, David H, Montalban, Xavier, Barkhof, Frederik, Radu, Ernst-Wilhelm, Metzig, Carola et al.
DOI: 10.1016/S1474-4422(09)70237-6

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial.

PMID: 19748319
Journal: LANCET NEUROLOGY
Year: 2009
Reference: Lancet Neurol. 2009 Nov;8(11):987-97.
Impact factor:
Publication type: Paper in international publication
Authors: Barkhof, Frederik; Bauer, Lars; Edan, Gilles; Freedman, Mark S; Hartung, Hans-Peter; Kappos, Ludwig; Lanius, Vivian; Metzig, Carola; Miller, David H; Montalban, Xavier et al.
DOI: 10.1016/S1474-4422(09)70237-6

Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy.

PMID: 19563586
Journal: DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
Year: 2009
Reference: Dev Med Child Neurol. 2009 Jun;51(6):436-45.
Impact factor: 2.561
Publication type: Paper in international publication
Authors: Fontan, D, Kanovsky, Petr, Bares, Martin, Severa, Stanislav, Richardson, Alan, Kanovsky, P, Kraus, J, Severa, S, Turconi, A C, Bonikowski, M et al.
DOI: 10.1111/j.1469-8749.2008.03264.x

Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy.

PMID: 19563586
Journal: DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
Year: 2009
Reference: Dev Med Child Neurol. 2009 Jun;51(6):436-45.
Impact factor:
Publication type: Paper in international publication
Authors: Bares, Martin; Benetin, J; Bonikowski, M; Cardo, E; Fontan, D; Jasinski, M; Jozwiak, M; Kanovsky, P; Kanovsky, Petr; Kraus, J et al.
DOI: 10.1111/j.1469-8749.2008.03264.x

Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders.

PMID: 19355849
Journal: Current Alzheimer Research
Year: 2009
Reference: Curr Alzheimer Res. 2009 Apr;6(2):144-51.
Impact factor: 4.132
Publication type: Paper in international publication
Authors: Dubois, Bruno, Flitman, Stephen, Frank-Garcia, Ana, Grosz, Daniel, Hock, Christoph, Jouanny, Pierre, Kirby, Louis, Knopman, David, Laurent, Bernard, Michel, Bernard et al.
DOI:

Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders.

PMID: 19355849
Journal: Current Alzheimer Research
Year: 2009
Reference: Curr Alzheimer Res. 2009 Apr;6(2):144-51.
Impact factor:
Publication type: Paper in international publication
Authors: Black, R; Boada Rovira, Merce; Brody, Mark; Corey-Bloom, Jody; Daniels, M; Dartigues, Jean-Francois; Doody, Rachelle; Dubois, Bruno; Flitman, Stephen; Fox, Nick C et al.
DOI:

Long-term results of the Spanish Protocol SO-95 for the treatment of non-metastatic high-grade osteosarcoma of the extremities in children.

PMID: 19531454
Journal: Clin Transl Oncol
Year: 2009
Reference: Clin Transl Oncol. 2009 Jun;11(6):387-92.
Impact factor:
Publication type: Letter or abstract
Authors: Munoz, Arturo, Alfaro, Jose, Pardo, Nuria, Garcia-Miguel, Purificacion, Quintero, Victor, Gros, Luis, Melero, Carmen, Antuna, Maria Jesus, Ocete, Guillermo, de Las Heras, Jorge et al.
DOI:

Long-term results of the Spanish Protocol SO-95 for the treatment of non-metastatic high-grade osteosarcoma of the extremities in children.

PMID: 19531454
Journal: Clin Transl Oncol
Year: 2009
Reference: Clin Transl Oncol. 2009 Jun;11(6):387-92.
Impact factor:
Publication type: Letter or abstract
Authors: Alfaro, Jose; Antuna, Maria Jesus; de Las Heras, Jorge; Garcia-Miguel, Purificacion; Gros, Luis; Huguet, Ramon; Maldonado, Maria Soledad; Melero, Carmen; Munoz, Arturo; Ocete, Guillermo et al.
DOI:

Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes.

PMID: 19920100
Journal: CLINICAL CANCER RESEARCH
Year: 2009
Reference: Clin Cancer Res. 2009 Dec 1;15(23):7381-8.
Impact factor: 6.488
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1158/1078-0432.CCR-09-1735

Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes.

PMID: 19920100
Journal: CLINICAL CANCER RESEARCH
Year: 2009
Reference: Clin Cancer Res. 2009 Dec 1;15(23):7381-8.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1158/1078-0432.CCR-09-1735

Low frequency electromagnetic radiation and hearing.

PMID: 19573254
Journal: JOURNAL OF LARYNGOLOGY AND OTOLOGY
Year: 2009
Reference: J Laryngol Otol. 2009 Nov;123(11):1204-11.
Impact factor: 0.796
Publication type: Paper in international publication
Authors: Morales, J, Garcia, M, Perez, C, Valverde, J V, Lopez-Sanchez, C, Garcia-Martinez, V, Quesada, J L et al.
DOI: 10.1017/S0022215109005684

Low frequency electromagnetic radiation and hearing.

PMID: 19573254
Journal: JOURNAL OF LARYNGOLOGY AND OTOLOGY
Year: 2009
Reference: J Laryngol Otol. 2009 Nov;123(11):1204-11.
Impact factor:
Publication type: Paper in international publication
Authors: Garcia, M; Garcia-Martinez, V; Lopez-Sanchez, C; Morales, J; Perez, C; Quesada, J L; Valverde, J V et al.
DOI: 10.1017/S0022215109005684

Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months.

PMID: 19018783
Journal: CLINICAL ENDOCRINOLOGY
Year: 2009
Reference: Clin Endocrinol (Oxf). 2009 Sep;71(3):351-7.
Impact factor: 3.398
Publication type: Paper in international publication
Authors: Ibanez, Lourdes, Lopez-Bermejo, Abel, Diaz, Marta, Enriquez, Goya, del Rio, Luis, de Zegher, Francis et al.
DOI: 10.1111/j.1365-2265.2008.03472.x

Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months.

PMID: 19018783
Journal: CLINICAL ENDOCRINOLOGY
Year: 2009
Reference: Clin Endocrinol (Oxf). 2009 Sep;71(3):351-7.
Impact factor:
Publication type: Paper in international publication
Authors: de Zegher, Francis; del Rio, Luis; Diaz, Marta; Enriquez, Goya; Ibanez, Lourdes; Lopez-Bermejo, Abel et al.
DOI: 10.1111/j.1365-2265.2008.03472.x

Lower concentrations of thrombin-antithrombin complex (TAT) correlate to higher recanalisation rates among ischaemic stroke patients treated with t-PA.

PMID: 19806263
Journal: THROMBOSIS AND HAEMOSTASIS
Year: 2009
Reference: Thromb Haemost. 2009 Oct;102(4):759-64.
Impact factor: 3.803
Publication type: Paper in international publication
Authors: Fernandez-Cadenas, Israel, Mendioroz, Maite, Munuera, Josep, Alvarez-Sabin, Jose, Rovira, Alex, Quiroga, Adoracion, Corbeto, Natalia, Rubiera, Marta, Delgado, Pilar, Rosell, Anna et al.
DOI: 10.1160/TH08-06-0398

Lower concentrations of thrombin-antithrombin complex (TAT) correlate to higher recanalisation rates among ischaemic stroke patients treated with t-PA.

PMID: 19806263
Journal: THROMBOSIS AND HAEMOSTASIS
Year: 2009
Reference: Thromb Haemost. 2009 Oct;102(4):759-64.
Impact factor:
Publication type: Paper in international publication
Authors: Alvarez-Sabin, Jose; Corbeto, Natalia; Delgado, Pilar; Fernandez-Cadenas, Israel; Mendioroz, Maite; Molina, Carlos A; Montaner, Joan; Munuera, Josep; Quiroga, Adoracion; Ribo, Marc et al.
DOI: 10.1160/TH08-06-0398

Lower zinc-alpha2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance.

PMID: 19622624
Journal: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Year: 2009
Reference: J Clin Endocrinol Metab. 2009 Nov;94(11):4499-507.
Impact factor: 6.325
Publication type: Paper in international publication
Authors: Selva, David M, Lecube, Albert, Hernandez, Cristina, Baena, Juan A, Fort, Jose M, Simo, Rafael et al.
DOI: 10.1210/jc.2009-0758

Lower zinc-alpha2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance.

PMID: 19622624
Journal: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Year: 2009
Reference: J Clin Endocrinol Metab. 2009 Nov;94(11):4499-507.
Impact factor:
Publication type: Paper in international publication
Authors: Baena, Juan A; Fort, Jose M; Hernandez, Cristina; Lecube, Albert; Selva, David M; Simo, Rafael et al.
DOI: 10.1210/jc.2009-0758